Navigation Links
Weight Loss Without Hunger!
Date:2/13/2009

Full Sense(TM) Device completes successful clinical evaluation

GRAND RAPIDS, Mich., Feb. 13 /PRNewswire/ -- Sentinel Group announced the completion of the first study of the Full Sense(TM) Device. The study was conducted at Galenia Hospital in Cancun, Mexico by American doctors Randal Baker MD, James Foote MD and Mexican doctor Jorge Trevino MD. The study protocol was designed to have the devices implanted for 6 weeks to evaluate weight loss, satiety (lack of hunger), safety, and removability.

The Full Sense(TM) Device is a stent like device placed through the mouth into the top of the stomach to cause satiety thus decreased hunger and increased fullness. It causes satiety by placing pressure on the bottom of the esophagus and the top of the stomach.

Patients not only lost significant weight in the study but also noted significant satiety with the device in place. Without the device they noted extreme hunger before meals whereas with the pressure from the Full Sense(TM) Device they experienced at most slight to no hunger before meals. The devices were removed safely and patients have stopped losing weight and are beginning to regain the weight that they had lost.

"The patients were extremely happy with the lack of hunger and resulting weight loss. They did not want the devices removed but reluctantly underwent removal per the protocol to demonstrate that the device could be easily removed," said Fred Walburn, PhD., President of Sentinel Group. "This technology represents potentially a new era of safe non-surgical weight loss treatment and offers hope for the millions of Americans who need treatment for obesity but can't afford the cost or possible complications of traditional weight loss surgery."

"Obesity is increasingly causing devastating effects on individuals and our society as a whole. This technology, I believe, offers the best opportunity yet to deliver consistent satiety and weight loss. Even many people with traditional weight loss surgery are experiencing significant hunger and subsequent weight regain. The potential to deliver satiety without classic incisions and surgery will give hope to many more people struggling with weight and weight related medical conditions," stated Randal Baker MD.

"The patients were very pleased with the results of the Full Sense(TM) Device," said Dr. Trevino, Head of Bariatric Surgery. "They are asking for the device to be implanted again!"

ABOUT GALENIA

The Galenia Hospital located in Cancun, Quintana Roo, Mexico is a modern facility with state of the art equipment which goes beyond the everyday services, with highly trained doctors and a wide range of medical specialties along with experienced people working for health care of national and international patients.

ABOUT SENTINEL GROUP

Sentinel Group is a medical device development company founded to commercialize patents owned by its principals and to assist physician inventors in commercializing their ideas. The company's intellectual property portfolio includes technologies in the areas of: bariatrics, colorectal anastomoses, diverticulitis, hiatal hernia, depression, Natural Orifice Translumenal Endoscopic Surgery (NOTES), Endoscopy and GERD. The Company's first product is the Full Sense(TM) Bariatric Device.

The Full Sense(TM) Device is not available in all markets pending regulatory clearance. Sentinel Group(R) and Full Sense(TM) Device are trademarks of Sentinel Group LLC.


'/>"/>
SOURCE Sentinel Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Losing Weight with Chocolate on Valentine's Day
2. Employee Weight Loss Programs Offered By Half of Employers Who Provide Wellness Programs
3. Losing weight can cure obstructive sleep apnea in overweight patients
4. How Much Weight Can They Lose in 90 Days?
5. ADA releases updated position statement on weight management
6. World Cancer Day Highlights Link Between Overweight and Cancer
7. Divorce, antidepressants, or weight gain/loss can add years to your face
8. Divorce, Antidepressants, or Weight Gain/Loss Can Add Years to Your Face
9. Growth hormone treatment after weight loss surgery prevents loss of muscle mass
10. Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) Appetite Control Formula
11. Dallas – Fort Worth Bariatric Surgeon Dr. David Kim One of Few in America Selected to Perform New Weight Loss Surgery Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known for ... people know that popular cosmetic fillers can enhance earlobes and rejuvenate ... director of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. ...
(Date:1/18/2017)... ... 2017 , ... Delaware farmer Rick Dickerson attended the 2017 Soybean Leadership ... farms about a thousand acres of soybeans, corn and wheat, and raises peas, sweet ... other vegetables for the fresh market. He also operates a roadside stand and raises ...
(Date:1/18/2017)... ... January 18, 2017 , ... Visually ... number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive sweating and hyperhidrosis are ... Dri created this infographic to explain the seven types of hyperhidrosis. This visual ...
(Date:1/18/2017)... ANN ARBOR, Mich. USA; SAN JOSE, Calif, USA; and SHANGHAI, ... ... (PRWEB) January 18, 2017 -- Global public ... pitcher to reduce arsenic V (pentavalent arsenic) to NSF/ANSI 53: ... Standard for drinking water treatment units. This certification verifies that ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced today ... compete in the Boston Marathon on April 17. From first-time participants to accomplished ... to join Team V and support the Foundation’s mission to declare victory over cancer. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Shire plc (LSE: SHP, NASDAQ: ... and Drug Administration (FDA) has acknowledged receipt of the ... for SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. ... for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to ... the designated Prescription Drug User Fee Act (PDUFA) action ...
(Date:1/19/2017)... FRANCISCO , January 19, 2017 The global  pacemaker ... new report by Grand View Research, Inc. The heightening prevalence of cardiac conditions ... the growth of Pacemaker globally. In addition, technological enhancements in these devices are ... ... Grand View Research Logo ...
(Date:1/19/2017)... , Jan. 18, 2017   Synthetic Biologics, ... company developing therapeutics designed to preserve the microbiome ... today confirmed plans to initiate a Phase 2b/3 ... reformulation of lovastatin lactone designed to reduce methane ... in the gut to treat the underlying cause ...
Breaking Medicine Technology: